CompletedNCT03373539
Neurotrophin Expression in Infants as a Predictor of Respiratory and Neurodevelopmental Outcomes
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Cleveland Clinic
- Principal Investigator
- Giovanni Piedimonte, MD, MDThe Cleveland Clinic
- Enrollment
- 70 enrolled
- Eligibility
- All sexes
- Timeline
- 2014 – 2019
Study locations (1)
- Cleveland Clinic, Cleveland, Ohio, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03373539 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGPHASE1NCT06589245Inhaled Ciclesonide Study in Preterm InfantsVenkatesh Sampath